Dr. Conklin joins the Sheikh Zayed Institute from the FDA Office of New Drugs. She is a principal investigator for the institute’s Systems Biology Initiative and is director of the Inflammatory Bowel Disease Center at Children’s National Medical Center.
Her clinical interests are focused on better ways to detect and manage depression and anxiety in children with inflammatory bowel disease. She is also interested in nutritional issues related to IBD.
Related Articles on Gastroenterologists:
Gastroenterologist Dr. Vincent Jabour Highlights Benefits of ASCs to Congressman
Gastroenterologist on the Move: Dr. Magdalena Averhoff Appointed to Florida Board of Medicine
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.
